(Q33400678)
Statements
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours (English)
T A Yap
H Cortes-Funes
H Shaw
R Rodriguez
D Olmos
R Lal
P C Fong
D S Tan
D Harris
J Capdevila
C Coronado
A Soto-Matos
C Fernández-Teruel
M Siguero
L Paz-Ares
1 reference
1 reference
1 reference
1 reference
1 reference